Gut-Brain Connect: How metaMe’s Digital Therapeutic Hopes To Rewire IBS Treatment 

Written By Rasel Kabir

metaMe Health CEO and ex-Takeda executive Tim Rudolphi and partner firm Indegene’s senior vice president Marut Setia discuss with Scrip plans for the FDA-authorized, gut-directed hypnotherapy Regulora®, including an openness to outcomes-based pricing and the wider go-to-market strategy.

READ MORE

Links to a third-party site and requires registration for access to the full article

Rasel Kabir

I'm Professional web Designer and Developer + SEO. I do have about 8+ years of experience in web development and proven track record of delivering sites successfully. I promise to find imaginative and professional ways to infuse life into

your products and services simply through the magic of my impeccable talents. Get in touch with me today to

give a new turn to your business.

https://raselkabir.com/
Next

metaMe Health partners with Launchit Ventures to market Regulora®, an FDA-cleared Prescription Digital Therapeutic for adults with IBS, in Canada